Occult hepatitis B in HIV-HCV coinfected patients

Author： Piroth Lionel   Lafon Marie-Edith   Binquet Christine   Bertillon Pascale   Gervais Anne   Lootvoet Enguerrand   Lang Jean-Marie   Jaureguiberry Jean   Chene Genevieve   Leport Catherine  

Publisher： Informa Healthcare

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.40, Iss.10, 2008-01, pp. : 835-839

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute and chronic immune biomarker changes during interferon/ribavirin treatment in HIV/HCV co‐infected patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 1, 2015-01 ,pp. : 25-36

John Wiley & Sons Inc

Access to resources Recommend Favorite

Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1‐coinfected patients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 9, 2015-09 ,pp. : 2090-2099

John Wiley & Sons Inc

Access to resources Recommend Favorite

P139: Development of treatment model for HIV/HCV co‐infected OST patients as the basis for scaling up access to HCV treatment for key populations in Ukraine

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 89-89

John Wiley & Sons Inc

Access to resources Recommend Favorite

Occult Hepatitis B Virus Infection in HIV-Infected Patients with Isolated Hepatitis B Core Antibody

By  

Intervirology, Vol. 51, Iss. 4, 2008-10 ,pp. : 270-274

Karger

Access to resources Recommend Favorite

Use of hepatitis B surface and “e” antigen quantification during extensive treatment with tenofovir in patients co‐infected with HIV‐HBV

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 795-804

John Wiley & Sons Inc

Access to resources Recommend Favorite